Nutr Diet Suppl. 2015;7:77-85. doi: 10.2147/NDS.S88888. Epub 2015 Oct 20.
Taurine and vitamin E supplementations have minimal effects on body composition, hepatic lipids, and blood hormone and metabolite concentrations in healthy Sprague Dawley rats.
Nutrition and dietary supplements
Portia S Allen, Andrew W Brown, Michelle M Bohan Brown, Walter H Hsu, Donald C Beitz
Affiliations
Affiliations
- Department of Animal Science, Iowa State University, Ames, Iowa, United States of America.
- Nutrition Obesity Research Center and Office of Energetics, University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
- Department of Biochemistry, Biophysics, and Molecular Biology, Iowa State University, Ames, Iowa, United States of America.
- Department of Biomedical Sciences, Iowa State University, Ames, Iowa, United States of America.
PMID: 26752960
PMCID: PMC4706234 DOI: 10.2147/NDS.S88888
Abstract
BACKGROUND: As prescriptions for off-label pharmaceutical use and autonomous administration of over-the-counter nutraceuticals become mainstream, thorough assessments of these compounds are warranted.
OBJECTIVE: To determine the effects of gemfibrozil, rosiglitazone, metformin, taurine, and vitamin E on body composition, hepatic lipids, and metabolic hormone and blood metabolite concentrations in a healthy, outbred rat cohort.
METHODS: Male Sprague Dawley rats were fed a purified 10 kcal% from fat diet for 56 days and assigned to diet alone (control) or diet plus oral administration of gemfibrozil (34 mg/kg), metformin (500 mg/kg), rosiglitazone (3 mg/kg), taurine (520 mg/kg), or vitamin E (200 mg/kg).
RESULTS: Rosiglitazone administration resulted in a 56% increase in carcass adiposity, cautioning potential prescriptive off-label use. Taurine supplementation had no adverse effects on evaluated parameters. A modest but significant increase in liver triacylglycerol content was observed with vitamin E supplementation compared with control (Δ 17.2 g triacylglycerol/100 g liver lipid).
CONCLUSIONS: The evaluated pharmaceuticals had effects in a healthy population similar to the reported effects in their target population and the nutraceuticals had minimal effects on the measured physiological parameters.
Keywords: animal model; gemfibrozil; metformin; thiazolidinedione
References
- J Biol Chem. 1988 Feb 25;263(6):2998-3004 - PubMed
- J Am Coll Cardiol. 2013 Aug 20;62(8):697-703 - PubMed
- Nat Rev Endocrinol. 2014 Mar;10(3):143-56 - PubMed
- J Nutr. 2011 Feb;141(2):261-6 - PubMed
- J Am Assoc Lab Anim Sci. 2010 May;49(3):316-22 - PubMed
- J Am Pharm Assoc Am Pharm Assoc. 1951 Mar;40(3):151-3 - PubMed
- Experientia. 1986 Apr 15;42(4):407-8 - PubMed
- Pharmacol Rep. 2005 Jul-Aug;57(4):498-503 - PubMed
- Circulation. 1998 Nov 10;98(19):2088-93 - PubMed
- Mayo Clin Proc. 2010 Nov;85(11):1033-41 - PubMed
- Free Radic Biol Med. 2007 Nov 15;43(10):1388-93 - PubMed
- Clin Endocrinol (Oxf). 2013 Aug;79(2):204-10 - PubMed
- Metabolism. 2010 Jan;59(1):46-53 - PubMed
- Adv Ther. 2009 Oct;26(10):893-907 - PubMed
- Br J Nutr. 1983 Sep;50(2):409-16 - PubMed
- Physiol Rev. 1992 Jan;72(1):101-63 - PubMed
- J Am Assoc Lab Anim Sci. 2006 Jan;45(1):98-105 - PubMed
- Clin Biochem. 1993 Feb;26(1):39-42 - PubMed
- J Biol Chem. 1957 May;226(1):497-509 - PubMed
- J Biol Chem. 2012 Dec 28;287(53):44121-9 - PubMed
- J Nutr. 1977 Aug;107(8):1418-26 - PubMed
- J Agric Food Chem. 2003 Apr 9;51(8):2105-10 - PubMed
- Atherosclerosis. 1996 Nov 15;127(1):91-101 - PubMed
- Nutr J. 2003 Oct 07;2:9 - PubMed
- Arch Intern Med. 2006 May 8;166(9):1021-6 - PubMed
- Am J Physiol Endocrinol Metab. 2006 Feb;290(2):E251-7 - PubMed
- Clin Chim Acta. 1993 Sep 30;218(2):223-8 - PubMed
- In Vivo. 2004 Jan-Feb;18(1):49-53 - PubMed
- Regul Toxicol Pharmacol. 2008 Apr;50(3):376-99 - PubMed
- Acta Biochim Pol. 2010;57(3):321-6 - PubMed
Publication Types
Grant support